CALR and acquired polycythemia vera: For example, MYSEC-PM (Myelofibrosis Secondary to PV and ET-Prognostic Model) [171] considers constitutional symptoms, anemia, circulating blasts, thrombocytopenia, advanced age, circulating blasts, and absence of CALR mutations as risk variables.